secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001178913-22-001980
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio appoints Miranda Toledano as CFO, CBO, and Head of Corp Strategy; prior CFO Ratan departs
--------------------------------------------------------------------------------

- Miranda Toledano appointed Chief Business Officer, CFO, and Head of Corporate Strategy effective May 16, 2022.
- Toledano loses independence; no longer serves on Compensation or Audit Committees; vacancies to be filled.
- Annual employer cost of $350,000; options for 500k shares at $2.02, vesting over 4 years (25% at year 1).
- Prior CFO Ramesh Ratan no longer with company; Dana Yaacov-Garbeli remains as principal accounting officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322001980/0001178913-22-001980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322001980/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-22-001980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer